Cited by 1,482Pancreatic function and diabetesNitric Oxide and Endothelin EffectsRedox biology and oxidative stress

Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction?

Open access
Evans, Joseph L., Goldfine, Ira D., Maddux, Betty A., Grodsky, Gerold M.·2003·Diabetes

Abstract

In both type 1 and type 2 diabetes, diabetic complications in target organs arise from chronic elevations of glucose. The pathogenic effect of high glucose, possibly in concert with fatty acids, is mediated to a significant extent via increased production of reactive oxygen species (ROS) and reactive nitrogen species (RNS) and subsequent oxidative stress. ROS and RNS directly oxidize and damage DNA, proteins, and lipids. In addition to their ability to directly inflict damage on macromolecules, ROS and RNS indirectly induce damage to tissues by activating a number of cellular stress-sensitive pathways. These pathways include nuclear factor-kappaB, p38 mitogen-activated protein kinase, NH(2)-terminal Jun kinases/stress-activated protein kinases, hexosamines, and others. In addition, there is evidence that in type 2 diabetes, the activation of these same pathways by elevations in glucose and free fatty acid (FFA) levels leads to both insulin resistance and impaired insulin secretion. Therefore, we propose here that the hyperglycemia-induced, and possibly FFA-induced, activation of stress pathways plays a key role in the development of not only the late complications in type 1 and type 2 diabetes, but also the insulin resistance and impaired insulin secretion seen in type 2 diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diabetes.52.1.1

Cites

105 of 105 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ROS can function as signaling molecules to activate MAPK family, including ERK, p38, and JNK.

    “ROS can function as signaling molecules to activate the MAPK family, including ERK, p38, and JNK (15, 25).”
  • Mitochondrial metabolism is also required for the transient, controlled production of ROS, which is required for the mitochondrial signaling pathways that trigger granule exocytosis.

    “Mitochondrial metabolism is also required for the transient, controlled production of ROS, which is required for the mitochondrial signaling pathways that trigger granule exocytosis (239, 240).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. DeFronzo RA: Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Review 5:177-269, 1997
  2. Robertson RP, Harmon JS, Tanaka Y, Sacchi G, Tran PO, Gleason CE, Poitout V: Glucose toxicity of the ␤-cell: cellular and molecular mecha- nisms. In Diabetes Mellitus: A Fundamental and Clinical Text. Le Roith D, Taylor SI, Olefsky JM, Eds. Philadelphia, Lippincott Williams & Wilkins, 2000, p. 125-132

Cited by

Sorted by citations

Authors
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M.
Affiliations
  • Medical Research Institute, San Francisco, California
  • University of California, San Francisco (US)
Venue
Diabetes
Published
2003-01-01
Volume
52
Issue
1
Pages
1-8
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2059467226
Cited by
1,482
References
105
Citations by year
2026: 24 · 2025: 42 · 2024: 42 · 2023: 48 · 2022: 52 · 2021: 50 · 2020: 66 · 2019: 74 · 2018: 69 · 2017: 75 · 2016: 77 · 2015: 92 · 2014: 92 · 2013: 88 · 2012: 89
FWCI
10.31
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American Diabetes Association
  • Diabetes Action Research and Education Foundation
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
Keywords
oxidative stress, reactive oxygen species, reactive nitrogen species, insulin resistance, beta-cell dysfunction, impaired insulin secretion, type 2 diabetes, type 1 diabetes, hyperglycemia, free fatty acids, NF-κB, p38 MAPK, hexosamine biosynthetic pathway, diabetes complications
MeSH terms
Animals, Diabetes Mellitus, Type 2, Humans, Hyperglycemia, Insulin Resistance, Islets of Langerhans, Signal Transduction, Oxidative Stress

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review